Novus Biologicals, LLC
Novus Biologicals, LLC, headquartered in the United States, is a leading provider of high-quality biological reagents and tools for the life sciences industry. Founded in 2006, the company has established a strong presence in key operational regions, including North America and Europe, by focusing on innovative solutions for research and diagnostics. Specialising in antibodies, proteins, and assay kits, Novus Biologicals distinguishes itself through its commitment to quality and customer support. The company’s extensive product portfolio caters to a diverse range of applications, from basic research to advanced clinical studies. With a reputation for reliability and scientific excellence, Novus Biologicals has achieved notable milestones, including partnerships with prominent research institutions and contributions to significant scientific advancements.
DitchCarbon Score
How does Novus Biologicals, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Novus Biologicals, LLC's score of 42 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Novus Biologicals, LLC, headquartered in the US, currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. However, as a current subsidiary of Bio-Techne Corporation, Novus Biologicals may inherit climate commitments and performance metrics from its parent company. Bio-Techne Corporation has established various climate initiatives, including Science Based Targets Initiative (SBTi) commitments and other sustainability efforts. While specific reduction targets for Novus Biologicals are not detailed, the overarching goals set by Bio-Techne Corporation may influence Novus's climate strategies. As part of its commitment to sustainability, Novus Biologicals is expected to align with the climate pledges and initiatives cascaded from Bio-Techne Corporation, which may include efforts to reduce emissions across Scope 1, 2, and 3 categories. However, without specific data or targets available for Novus Biologicals, the exact nature of these commitments remains vague. In summary, while Novus Biologicals, LLC does not currently provide specific emissions data or reduction targets, it is positioned within a corporate structure that prioritises climate action through its parent company, Bio-Techne Corporation.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 3,338,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 10,290,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Novus Biologicals, LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
